Top 200 Orgs
Top Orgs by Specialty
How We Rank
What's My Rank?
What's My Popularity Score?
In My Orgs?
In My Specialities?
In My Geography?
In My Age?
My Mentors, Collaborators,
Associates, Peers, Buddies
Keep Me Up To Date
People Making News
Latest Research From
People of Consequence (61350)
1. Peter Kowey
2. Lawrence W. Bassett
University of California
3. Robert S Kerbel
University of Toronto
4. Yehuda Shoenfeld
Sheba Medical Center
5. Paul Weiss
Gala Biotech business unit of Cardinal Health
Orgs of Consequence (17716)
Terms of Consequence
P. Jeffrey Conn
P. Jeffrey Conn
Presented at Events Covering:
Drug Design, Neuroscience, Physiology
Areas of Interest:
BSN Rank: 129 / 2656
Accomplish Score: 1860
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 211
We'll Post Your CV for Free!
Speaking/Presenting-Abstract/Poster at Mtg: 4 (52 / 0)
Partnering with Big Pharma to Develop mGluR Allosteric Modulators for CNS Disorders: From HTS to Clinical Candidates (2011)
Early-Stage Drug Discovery (Z2) | Partnering with Big Pharma to Develop mGluR Allosteric Modulators for CNS Disorders: From HTS to Clinical Candidates (2011)
Discovery of mGluR4 Potentiators for Symptomatic and Disease-Modifying Treatment of PD (2009)
Honors and Awards: 19 (190 / 0)
Distinguished Alumnus of the Year Award (2008)
Award for Excellence in Pharmacology and Toxicology (2008)
Astellas Award in Translational Pharmacology (2007)
Clinical Trial Activity: 0 (0 / 0)
Grant Support: 33 (297 / 0)
Modulators of Metabotropic Glutamate Receptor Subtype 2 for Cocaine Dependence (2008 - 2011)
Discovery of novel allosteric modulators of mGluR4 for treatment of Parkinsonâs disease (2007 - 2011)
Functional effects of mGluR potentiators in the CNS (2006 - 2011)
Patents Pending: 0 (0 / 0)
Journal - Editor/Reviewer: 0 (0 / 0)
Peer Reviewed Papers, Books, Chapters: 220 (1320 / 0)
Heterobiaryl and heterobiaryl ether derived M5 positive allosteric modulators (2011)
Molecular switches on mGluR allosteric ligands that modulate modes of Pharmacology (2011)
Discovery of molecular switches within the ADX-47273 mGlu5 PAM scaffold that modulate modes of pharmacology to afford potent mGlu5 NAMs, PAMs, and partial antagonists (2011)
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
Membership in Professional Societies: 0 (0 / 0)
White Papers: 0 (0 / 0)
Registered on BiotechScienceNews: 1
Advertise With Us
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.
Copyright © 2008 Biotech Science News LLC. All rights reserved